These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 29127727)

  • 1. Diversity in peptide recognition by the SH2 domain of SH2B1.
    McKercher MA; Guan X; Tan Z; Wuttke DS
    Proteins; 2018 Feb; 86(2):164-176. PubMed ID: 29127727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodal Recognition of Diverse Peptides by the C-Terminal SH2 Domain of Phospholipase C-γ1 Protein.
    McKercher MA; Guan X; Tan Z; Wuttke DS
    Biochemistry; 2017 Apr; 56(16):2225-2237. PubMed ID: 28376302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of electrostatic interactions in SH2 domain recognition: salt-dependence of tyrosyl-phosphorylated peptide binding to the tandem SH2 domain of the Syk kinase and the single SH2 domain of the Src kinase.
    Grucza RA; Bradshaw JM; Mitaxov V; Waksman G
    Biochemistry; 2000 Aug; 39(33):10072-81. PubMed ID: 10955995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical role of the Src homology 2 (SH2) domain of neuronal SH2B1 in the regulation of body weight and glucose homeostasis in mice.
    Morris DL; Cho KW; Rui L
    Endocrinology; 2010 Aug; 151(8):3643-51. PubMed ID: 20484460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissection of the energetic coupling across the Src SH2 domain-tyrosyl phosphopeptide interface.
    Lubman OY; Waksman G
    J Mol Biol; 2002 Feb; 316(2):291-304. PubMed ID: 11851339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of SH2B2beta as an inhibitor for SH2B1- and SH2B2alpha-promoted Janus kinase-2 activation and insulin signaling.
    Li M; Li Z; Morris DL; Rui L
    Endocrinology; 2007 Apr; 148(4):1615-21. PubMed ID: 17204555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determining folding and binding properties of the C-terminal SH2 domain of SHP2.
    Nardella C; Malagrinò F; Pagano L; Rinaldo S; Gianni S; Toto A
    Protein Sci; 2021 Dec; 30(12):2385-2395. PubMed ID: 34605082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor.
    Nioche P; Liu WQ; Broutin I; Charbonnier F; Latreille MT; Vidal M; Roques B; Garbay C; Ducruix A
    J Mol Biol; 2002 Feb; 315(5):1167-77. PubMed ID: 11827484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hierarchy of simulation models in predicting molecular recognition mechanisms from the binding energy landscapes: structural analysis of the peptide complexes with SH2 domains.
    Verkhivker GM; Bouzida D; Gehlhaar DK; Rejto PA; Schaffer L; Arthurs S; Colson AB; Freer ST; Larson V; Luty BA; Marrone T; Rose PW
    Proteins; 2001 Dec; 45(4):456-70. PubMed ID: 11746693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface plasmon resonance thermodynamic and kinetic analysis as a strategic tool in drug design. Distinct ways for phosphopeptides to plug into Src- and Grb2 SH2 domains.
    de Mol NJ; Dekker FJ; Broutin I; Fischer MJ; Liskamp RM
    J Med Chem; 2005 Feb; 48(3):753-63. PubMed ID: 15689159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural insight into the binding diversity between the Tyr-phosphorylated human ephrinBs and Nck2 SH2 domain.
    Ran X; Song J
    J Biol Chem; 2005 May; 280(19):19205-12. PubMed ID: 15764601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational determinants of phosphotyrosine peptides complexed with the Src SH2 domain.
    Nachman J; Gish G; Virag C; Pawson T; Pomès R; Pai E
    PLoS One; 2010 Jun; 5(6):e11215. PubMed ID: 20574521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational investigation of the specificity determining region of the Src SH2 domain.
    Bradshaw JM; Mitaxov V; Waksman G
    J Mol Biol; 2000 Jun; 299(2):521-35. PubMed ID: 10860756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probing the "two-pronged plug two-holed socket" model for the mechanism of binding of the Src SH2 domain to phosphotyrosyl peptides: a thermodynamic study.
    Bradshaw JM; Grucza RA; Ladbury JE; Waksman G
    Biochemistry; 1998 Jun; 37(25):9083-90. PubMed ID: 9636054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative mode of binding to phosphotyrosyl peptides by Src homology-2 domains.
    Qin C; Wavreille AS; Pei D
    Biochemistry; 2005 Sep; 44(36):12196-202. PubMed ID: 16142918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SH2B1 (SH2-B) and JAK2: a multifunctional adaptor protein and kinase made for each other.
    Maures TJ; Kurzer JH; Carter-Su C
    Trends Endocrinol Metab; 2007; 18(1):38-45. PubMed ID: 17140804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure, dynamics, and binding thermodynamics of the v-Src SH2 domain: implications for drug design.
    Taylor JD; Ababou A; Fawaz RR; Hobbs CJ; Williams MA; Ladbury JE
    Proteins; 2008 Dec; 73(4):929-40. PubMed ID: 18536014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of Src-like adaptor protein 2 reveals close association of SH3 and SH2 domains through β-sheet formation.
    Wybenga-Groot LE; McGlade CJ
    Cell Signal; 2013 Dec; 25(12):2702-8. PubMed ID: 24018043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superbinder SH2 domains act as antagonists of cell signaling.
    Kaneko T; Huang H; Cao X; Li X; Li C; Voss C; Sidhu SS; Li SS
    Sci Signal; 2012 Sep; 5(243):ra68. PubMed ID: 23012655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The SH2B1 adaptor protein associates with a proximal region of the erythropoietin receptor.
    Javadi M; Hofstätter E; Stickle N; Beattie BK; Jaster R; Carter-Su C; Barber DL
    J Biol Chem; 2012 Jul; 287(31):26223-34. PubMed ID: 22669948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.